Clinical Trials Directory

Trials / Completed

CompletedNCT01379001

Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusion MRI

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Hebrew SeniorLife · Academic / Other
Sex
All
Age
21 Years – 80 Years
Healthy volunteers
Accepted

Summary

This research study will look at how medications affect the pattern of blood flow in the brain. This study will use a special type of MRI (magnetic resonance imaging) scan called perfusion MRI to make measurements of cerebral (brain) blood flow. The medications we will use in this study are scopolamine (commonly used to treat motion sickness), mecamylamine (used to treat high blood pressure), and donepezil (used to treat memory loss). Cognitive testing will also be obtained, and correlated with the blood flow patterns in the brain.

Detailed description

Project Summary: This research project will investigate the value of combined pharmacologic manipulation and arterial spin-labeled perfusion MRI (pharmacologic ASL-pMRI) as an in vivo probe of cholinergic function. Methods to investigate cholinergic function in vivo are needed to better understand the role of acetylcholine in the physiology of the cerebral cortex, and in cognitive processes in health and in disease states. In this study, pharmacologic ASL-pMRI will be used to characterize the normal cerebral perfusion response to cholinergic manipulation in young healthy subjects. Cognitive measures will also be obtained and correlated with cerebral perfusion changes. Pharmacologic ASL-pMRI and cognitive testing will then be used to study how the cholinergic response is altered with normal aging and in delirium

Conditions

Interventions

TypeNameDescription
DRUGScopolamineScopolamine 0.4mg IM x 1 dose; adjustment in older group for weight (0.4mg/70kg)
DRUGPlaceboIM or PO placebo
DRUGDonepezildonepezil 5mg PO x 1

Timeline

Start date
2008-07-01
Primary completion
2013-01-01
Completion
2013-01-01
First posted
2011-06-23
Last updated
2013-01-04

Source: ClinicalTrials.gov record NCT01379001. Inclusion in this directory is not an endorsement.